NCT00535834 Studying Stored Samples From Patients With Localized Prostate Cancer Treated on Clinical Trial NCI-00-C-0154 Status COMPLETED Phase N/A
NCT00534196 Implant Radiation Therapy Using Radioactive Iodine in Treating Patients With Localized Prostate Cancer Status COMPLETED Phase N/A
NCT00528866 Radiation Therapy, Androgen Suppression, and Docetaxel in Treating Patients With High-Risk Prostate Cancer Who Have Undergone Radical Prostatectomy Status COMPLETED Phase PHASE2
NCT00526591 Everolimus in Treating Patients With Newly Diagnosed Localized Prostate Cancer Status TERMINATED Phase PHASE2
NCT00526331 Evaluation of Arterial Pressure Based Cardiac Output for Goal-Directed Perioperative Therapy Status COMPLETED Phase PHASE4
NCT00524589 Calcitriol and Dexamethasone in Treating Patients With Prostate Cancer That Did Not Respond to Hormone Therapy Status TERMINATED Phase PHASE2
NCT00523484 Casodex/Zoladex Hormonal therApy Study for assessMent of Correlation Between PSA & BAI in prOstate Cancer patieNts Status COMPLETED Phase N/A
NCT00520546 Clinical Value of FEC-PET Combined With Endorectal MRI for Pre-therapeutic Staging of Prostate Cancer Status COMPLETED Phase PHASE3
NCT00519233 AGS-1C4D4 in Patients With Advanced Hormone Refractory Prostate Cancer Status COMPLETED Phase PHASE1
NCT00515112 Testosterone Replacement in Men With Non-Metastatic Castrate Resistant Prostate Cancer Status TERMINATED Phase PHASE2
NCT00514540 Carboplatin Plus Docetaxel (Taxotere) in Anaplastic Prostate Cancer Status COMPLETED Phase PHASE2
NCT00514267 An Open-Label Study of YM155 + Docetaxel in Subjects With Advanced Hormone Refractory Prostate Cancer and Other Solid Tumors Status COMPLETED Phase PHASE1/PHASE2
NCT00514072 Vaccine Therapy in Treating Patients With Stage D0 Prostate Cancer Status UNKNOWN Phase PHASE2
NCT00513721 Retrospective Study of Positive Biopsy Specimens on Patients Undergoing a Prostatectomy Status COMPLETED Phase N/A
NCT00511576 Study to Evaluate Combination Treatment of MGCD0103 and Docetaxel (Taxotere®) for Subjects With Advanced Cancer Tumors Status TERMINATED Phase PHASE1